Progesterone receptors in normal breast development and breast cancer
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Progesterone receptors in normal breast development and breast cancer
Authors
Keywords
-
Journal
Essays in Biochemistry
Volume -, Issue -, Pages -
Publisher
Portland Press Ltd.
Online
2021-06-02
DOI
10.1042/ebc20200163
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The androgen receptor is a tumor suppressor in estrogen receptor–positive breast cancer
- (2021) Theresa E. Hickey et al. NATURE MEDICINE
- Phasing the intranuclear organization of steroid hormone receptors
- (2021) Martin Stortz et al. BIOCHEMICAL JOURNAL
- Increased androgen receptor expression in estrogen receptor-positive/progesterone receptor-negative breast cancer
- (2020) Ximena García et al. BREAST CANCER RESEARCH AND TREATMENT
- Cytokeratin 5 alters β-catenin dynamics in breast cancer cells
- (2020) Olivia McGinn et al. ONCOGENE
- Progesterone and Breast Cancer: an NCI Workshop Report
- (2020) Neeraja Sathyamoorthy et al. Hormones & Cancer
- Progesterone and breast
- (2020) Caroline A. Lamb et al. BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY
- Steroid Receptors as MAPK Signaling Sensors in Breast Cancer: Let the Fates Decide
- (2020) Amy R Dwyer et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Progesterone and Progesterone Receptors in Breast Cancer: Past, Present, Future
- (2020) Kathryn B. Horwitz et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- The secreted protease Adamts18 links hormone action to activation of the mammary stem cell niche
- (2020) Dalya Ataca et al. Nature Communications
- Clinical association of progesterone receptor isoform A with breast cancer metastasis consistent with its unique mechanistic role in preclinical models
- (2020) Rayna Rosati et al. BMC CANCER
- 90 YEARS OF PROGESTERONE: Progesterone receptor signaling in the normal breast and its implications for cancer
- (2020) Cathrin Brisken et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Local Transdermal Delivery of Telapristone Acetate Through Breast Skin, Compared With Oral Treatment: A Randomized Double‐Blind, Placebo‐Controlled Phase II Trial
- (2020) Oukseub Lee et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Extracellular matrix-bound FGF2 mediates estrogen receptor signaling and therapeutic response in breast cancer
- (2020) Josh W. DiGiacomo et al. MOLECULAR CANCER RESEARCH
- Alterations in Progesterone Receptor Isoform Balance in Normal and Neoplastic Breast Cells Modulates the Stem Cell Population
- (2020) María Sol Recouvreux et al. Cells
- Enhanced antitumor immunity via endocrine therapy prevents mammary tumor relapse and increases immune checkpoint blockade sensitivity
- (2020) Gonzalo R. Sequeira et al. CANCER RESEARCH
- Mammary development in the embryo and adult: new insights into the journey of morphogenesis and commitment
- (2020) Christine J. Watson et al. DEVELOPMENT
- Sequential Colocalization of ERa, PR, and AR Hormone Receptors Using Confocal Microscopy Enables New Insights into Normal Breast and Prostate Tissue and Cancers
- (2020) Miguel Chenlo et al. Cancers
- Breast Cancer Treatment
- (2019) Adrienne G. Waks et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- FGF2 induces breast cancer growth through ligand‐independent activation and recruitment of ERα and PRBΔ4 isoform to MYC regulatory sequences
- (2019) Sebastián Giulianelli et al. INTERNATIONAL JOURNAL OF CANCER
- Progestogens and PGRMC1-dependent breast cancer tumor growth: An in-vitro and xenograft study
- (2019) Xiangyan Ruan et al. MATURITAS
- Selective progesterone receptor modulators in early stage breast cancer: a randomized, placebo-controlled Phase II window of opportunity trial using telapristone acetate.
- (2019) Oukseub Lee et al. CLINICAL CANCER RESEARCH
- Progesterone and breast cancer
- (2019) Britton Trabert et al. ENDOCRINE REVIEWS
- Nuclear action of FGF members in endocrine-related tissues and cancer: Interplay with steroid receptor pathways
- (2019) Virginia Figueroa et al. STEROIDS
- Molecular mechanisms underlying progesterone receptor action in breast cancer: Insights into cell proliferation and stem cell regulation
- (2019) Mauro E. Cenciarini et al. STEROIDS
- Biological and clinical impact of imbalanced progesterone receptor isoform ratios in breast cancer
- (2018) Caroline A Lamb et al. ENDOCRINE-RELATED CANCER
- Progestin-only and combined oral contraceptives and receptor-defined premenopausal breast cancer risk: The Norwegian Women and Cancer Study
- (2018) Marit Busund et al. INTERNATIONAL JOURNAL OF CANCER
- Estrogen and progesterone signalling in the normal breast and its implications for cancer development
- (2018) Heidi N. Hilton et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Increased High Molecular Weight FGF2 in Endocrine-Resistant Breast Cancer
- (2018) Ana Sahores et al. Hormones & Cancer
- Phase I study of onapristone, a type I antiprogestin, in female patients with previously treated recurrent or metastatic progesterone receptor-expressing cancers
- (2018) Paul H. Cottu et al. PLoS One
- Intraductal patient-derived xenografts of estrogen receptor α-positive breast cancer recapitulate the histopathological spectrum and metastatic potential of human lesions
- (2018) Maryse Fiche et al. JOURNAL OF PATHOLOGY
- Oestrogen receptor α AF-1 and AF-2 domains have cell population-specific functions in the mammary epithelium
- (2018) Stéphanie Cagnet et al. Nature Communications
- Progesterone receptor A promotes invasiveness and metastasis of luminal breast cancer by suppressing regulation of critical microRNAs by estrogen
- (2017) Thomas McFall et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Posttranslationally modified progesterone receptors direct ligand-specific expression of breast cancer stem cell-associated gene programs
- (2017) Todd P. Knutson et al. Journal of Hematology & Oncology
- Progesterone Receptor Isoform Ratio: A Breast Cancer Prognostic and Predictive Factor for Antiprogestin Responsiveness
- (2017) Paola A. Rojas et al. JNCI-Journal of the National Cancer Institute
- The presence of a membrane-bound progesterone receptor induces growth of breast cancer with norethisterone but not with progesterone: A xenograft model
- (2017) Yue Zhao et al. MATURITAS
- Progesterone receptor isoforms, agonists and antagonists differentially reprogram estrogen signaling
- (2017) Hari Singhal et al. Oncotarget
- Progesterone Receptor Isoform Ratio: A Breast Cancer Prognostic and Predictive Factor for Antiprogestin Responsiveness
- (2017) Paola A. Rojas et al. JNCI-Journal of the National Cancer Institute
- Epidermal loss of Gαq confers a migratory and differentiation defect in keratinocytes
- (2017) Colleen L. Doçi et al. PLoS One
- Modifications to glucocorticoid and progesterone receptors alter cell fate in breast cancer
- (2016) Katherine A Leehy et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Early dissemination seeds metastasis in breast cancer
- (2016) Hedayatollah Hosseini et al. NATURE
- Epigenetic control of adult stem cell function
- (2016) Alexandra Avgustinova et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Anti-Tumoral Effects of Anti-Progestins in a Patient-Derived Breast Cancer Xenograft Model
- (2016) Nathalie Esber et al. Hormones & Cancer
- Genomic agonism and phenotypic antagonism between estrogen and progesterone receptors in breast cancer
- (2016) H. Singhal et al. Science Advances
- Progesterone receptor A predominance is a discriminator of benefit from endocrine therapy in the ATAC trial
- (2015) Patricia A. Mote et al. BREAST CANCER RESEARCH AND TREATMENT
- Progesterone and Wnt4 control mammary stem cells via myoepithelial crosstalk
- (2015) R. D. Rajaram et al. EMBO JOURNAL
- Progesterone and Overlooked Endocrine Pathways in Breast Cancer Pathogenesis
- (2015) Cathrin Brisken et al. ENDOCRINOLOGY
- Progesterone action in breast, uterine, and ovarian cancers
- (2015) C. H. Diep et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Progesterone receptor modulates ERα action in breast cancer
- (2015) Hisham Mohammed et al. NATURE
- Steroid induction of therapy-resistant cytokeratin-5-positive cells in estrogen receptor-positive breast cancer through a BCL6-dependent mechanism
- (2015) C R Goodman et al. ONCOGENE
- A Progesterone-CXCR4 Axis Controls Mammary Progenitor Cell Fate in the Adult Gland
- (2015) Yu-Jia Shiah et al. Stem Cell Reports
- RANK Signaling Amplifies WNT-Responsive Mammary Progenitors through R-SPONDIN1
- (2015) Purna A. Joshi et al. Stem Cell Reports
- The effectiveness of nano chemotherapeutic particles combined with mifepristone depends on the PR isoform ratio in preclinical models of breast cancer
- (2015) Gonzalo Sequeira et al. Oncotarget
- Role of nuclear progesterone receptor isoforms in uterine pathophysiology
- (2014) B. Patel et al. HUMAN REPRODUCTION UPDATE
- Progestin and antiprogestin responsiveness in breast cancer is driven by the PRA/PRB ratioviaAIB1 or SMRT recruitment to theCCND1andMYCpromoters
- (2014) Victoria Wargon et al. INTERNATIONAL JOURNAL OF CANCER
- Histone Demethylase Jumonji AT-rich Interactive Domain 1B (JARID1B) Controls Mammary Gland Development by Regulating Key Developmental and Lineage Specification Genes
- (2014) Mike Ran Zou et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Progesterone receptor-B enhances estrogen responsiveness of breast cancer cells via scaffolding PELP1- and estrogen receptor-containing transcription complexes
- (2014) A R Daniel et al. ONCOGENE
- Randomized phase II study of lonaprisan as second-line therapy for progesterone receptor-positive breast cancer
- (2013) W. Jonat et al. ANNALS OF ONCOLOGY
- Polycomb group geneEzh2regulates mammary gland morphogenesis and maintains the luminal progenitor pool
- (2013) Ewa Malgorzata Michalak et al. STEM CELLS
- Global Changes in the Mammary Epigenome Are Induced by Hormonal Cues and Coordinated by Ezh2
- (2013) Bhupinder Pal et al. Cell Reports
- Estrogen Receptor Alpha Mediates Progestin-Induced Mammary Tumor Growth by Interacting with Progesterone Receptors at the Cyclin D1/MYC Promoters
- (2012) S. Giulianelli et al. CANCER RESEARCH
- Progesterone Receptor Isoform Functions in Normal Breast Development and Breast Cancer
- (2012) Anastasia Kariagina et al. CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION
- Antiprogestins in breast cancer treatment: are we ready?
- (2012) Claudia Lanari et al. ENDOCRINE-RELATED CANCER
- Progestin suppression of miR-29 potentiates dedifferentiation of breast cancer cells via KLF4
- (2012) D M Cittelly et al. ONCOGENE
- Mammary gland development
- (2012) Hector Macias et al. Wiley Interdisciplinary Reviews-Developmental Biology
- Interaction between FGFR-2, STAT5, and Progesterone Receptors in Breast Cancer
- (2011) J. P. Cerliani et al. CANCER RESEARCH
- ID4 regulates mammary gland development by suppressing p38MAPK activity
- (2011) J. Dong et al. DEVELOPMENT
- Progesterone regulation of stem and progenitor cells in normal and malignant breast
- (2011) Sunshine Daddario Axlund et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Classical membrane progesterone receptors in murine mammary carcinomas: agonistic effects of progestins and RU-486 mediating rapid non-genomic effects
- (2010) María Cecilia Bottino et al. BREAST CANCER RESEARCH AND TREATMENT
- Hypermethylation of the progesterone receptor A in constitutive antiprogestin-resistant mouse mammary carcinomas
- (2010) Victoria Wargon et al. BREAST CANCER RESEARCH AND TREATMENT
- Cytokeratin 5 positive cells represent a steroid receptor negative and therapy resistant subpopulation in luminal breast cancers
- (2010) Peter Kabos et al. BREAST CANCER RESEARCH AND TREATMENT
- MPA-induced gene expression and stromal and parenchymal gene expression profiles in luminal murine mammary carcinomas with different hormonal requirements
- (2010) Sebastián Giulianelli et al. BREAST CANCER RESEARCH AND TREATMENT
- RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis
- (2010) Eva Gonzalez-Suarez et al. NATURE
- Control of mammary stem cell function by steroid hormone signalling
- (2010) Marie-Liesse Asselin-Labat et al. NATURE
- Progesterone induces adult mammary stem cell expansion
- (2010) Purna A. Joshi et al. NATURE
- Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer
- (2010) Daniel Schramek et al. NATURE
- Two distinct mechanisms underlie progesterone-induced proliferation in the mammary gland
- (2010) M. Beleut et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hormone Action in the Mammary Gland
- (2010) C. Brisken et al. Cold Spring Harbor Perspectives in Biology
- Estrogen Receptor, Progesterone Receptor, and Glucocorticoid Receptor Expression in Normal Breast Tissue, Breast In Situ Carcinoma, and Invasive Breast Cancer
- (2010) Frederic Buxant et al. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
- DNA Replication Licensing and Progenitor Numbers Are Increased by Progesterone in Normal Human Breast
- (2009) J. Dinny Graham et al. ENDOCRINOLOGY
- Potentiation of the antitumor effect of tamoxifen by combination with the antiprogestin onapristone
- (2009) Tsuyuki Nishino et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Reversal of antiprogestin resistance and progesterone receptor isoform ratio in acquired resistant mammary carcinomas
- (2008) Victoria Wargon et al. BREAST CANCER RESEARCH AND TREATMENT
- Systematic Expression Analysis and Antibody Screening Do Not Support the Existence of Naturally Occurring Progesterone Receptor (PR)-C, PR-M, or Other Truncated PR Isoforms
- (2008) Annemarie Samalecos et al. ENDOCRINOLOGY
- Strain-Specific Differences in the Mechanisms of Progesterone Regulation of Murine Mammary Gland Development
- (2008) Mark D. Aupperlee et al. ENDOCRINOLOGY
- Nuclear matrix binding is critical for progesterone receptor movement into nuclear foci
- (2008) J. Dinny Graham et al. FASEB JOURNAL
- The effect of mifepristone on breast cell proliferation in premenopausal women evaluated through fine needle aspiration cytology
- (2008) M. Engman et al. HUMAN REPRODUCTION
- Carcinoma-associated fibroblasts activate progesterone receptors and induce hormone independent mammary tumor growth: A role for the FGF-2/FGFR-2 axis
- (2008) Sebastián Giulianelli et al. INTERNATIONAL JOURNAL OF CANCER
- Rare steroid receptor-negative basal-like tumorigenic cells in luminal subtype human breast cancer xenografts
- (2008) K. B. Horwitz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started